Keli Walbert - Jan 8, 2025 Form 3 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role: Director
Signature: /s/ David Watson, attorney-in-fact for Keli Walbert
Stock symbol: APLS
Transactions as of: Jan 8, 2025
Transactions value $: $0
Form type: 3
Date filed: 1/10/2025, 05:38 PM
SEC: View on sec.gov

No securities are beneficially owned.